[Malignant neuroleptic syndrome and Clostridium difficile: causal association or mere coincidence?]

Med Intensiva. 2012 Jan-Feb;36(1):63. doi: 10.1016/j.medin.2011.10.002. Epub 2011 Dec 9.
[Article in Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / pharmacokinetics
  • Antipsychotic Agents / therapeutic use
  • Bromocriptine / therapeutic use
  • Clostridioides difficile / isolation & purification*
  • Clostridium Infections / complications*
  • Combined Modality Therapy
  • Dantrolene / therapeutic use
  • Dehydration / etiology
  • Dehydration / metabolism
  • Diagnosis, Differential
  • Female
  • Fluid Therapy
  • Haloperidol / adverse effects*
  • Haloperidol / pharmacokinetics
  • Haloperidol / therapeutic use
  • Humans
  • Neuroleptic Malignant Syndrome / diagnosis
  • Neuroleptic Malignant Syndrome / drug therapy
  • Neuroleptic Malignant Syndrome / etiology*
  • Neuroleptic Malignant Syndrome / therapy
  • Risk Factors
  • Schizophrenia / complications
  • Schizophrenia / drug therapy

Substances

  • Antipsychotic Agents
  • Bromocriptine
  • Dantrolene
  • Haloperidol